ArticleIJID regions2026
Human papillomavirus prevalence and ThinPrep cytologic test results among 45,167 women in Shenzhen: A retrospective analysis.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To analyze human papillomavirus (HPV) infection status and ThinPrep cytologic test results among women undergoing health examinations at a tertiary hospital in Shenzhen, providing baseline data for cervical cancer prevention and treatment in this region. Methods: We retrospectively analyzed HPV and ThinPrep cytologic test results from 45,167 women who received health examinations at Shenzhen Maternity and Child Healthcare Hospital between November 2018 and June 2024. Results: The overall HPV infection rate was 11.57%, with single and multiple infections accounting for 79.33% and 20.67%, respectively. The most prevalent high-risk genotypes were HPV52, 53, 58, 51, and 68. Age-specific analysis revealed the highest infection rates in the ≤20 years age group (25%) and ≥71 years age group (15.75%), showing a U-shaped age-specific distribution. By marital status, unmarried women had the highest infection rate (22.43%) compared to married women (10.92%). The ThinPrep cytologic test positivity rate was 3.92%, and the proportion of patients positive for HPV and ThinPrep cytologic test was 1.42%. Notably, HPV prevalence showed a progressive increase corresponding to the severity of cervical tissue lesions. Conclusion: The HPV infection rate among women in Shenzhen remains manageable. However, particular attention should be paid to the risk of infection with high-risk subtypes and in specific populations, such as the young, the elderly, and unmarried women. These findings provide epidemiological evidence for optimizing cervical cancer screening strategies in Shenzhen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.